Forte Biosciences (FBRX) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free FBRX Stock Alerts $0.74 +0.02 (+2.76%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Forte Biosciences Stock Price Performance5 Day Performance+2.86%1 Month Performance+0.62%3 Month Performance+16.59%6 Month Performance+67.01%Year-To-Date Performance-10.61%1 Year Performance-32.61% Receive FBRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… FBRX Stock Chart for Friday, May, 10, 2024 FBRX Chart by TradingView Forte Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$0.75$0.74-1.55%$0.75$0.718,251 shs$26.91 million05/08/2024$0.71$0.75+5.50%$0.75$0.7313,497 shs$27.33 million05/07/2024$0.72$0.71-1.26%$0.75$0.7110,400 shs$25.91 million05/06/2024$0.71$0.72+0.83%$0.75$0.7211,555 shs$26.24 million05/03/2024$0.69$0.71+3.46%$0.73$0.6911,841 shs$26.02 million05/02/2024$0.67$0.69+2.86%$0.73$0.6711,051 shs$25.15 million Get the Latest News and Ratings for FBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$0.73$0.67-8.21%$0.75$0.6433,337 shs$24.42 million04/30/2024$0.73$0.73+0.83%$0.77$0.7122,631 shs$26.61 million04/29/2024$0.72$0.73+1.21%$0.74$0.7113,576 shs$26.39 million04/26/2024$0.74$0.72-3.07%$0.74$0.715,783 shs$26.07 million04/25/2024$0.71$0.74+4.08%$0.74$0.712,845 shs$26.90 million04/24/2024$0.74$0.71-3.87%$0.74$0.7114,300 shs$25.84 million04/23/2024$0.72$0.74+2.58%$0.77$0.714,626 shs$26.89 million04/22/2024$0.73$0.72-1.91%$0.75$0.7216,031 shs$26.20 million04/19/2024$0.78$0.73-5.90%$0.78$0.738,346 shs$26.72 million04/18/2024$0.74$0.78+5.41%$0.78$0.7357,449 shs$28.39 million04/17/2024$0.73$0.74+1.59%$0.78$0.7357,260 shs$26.93 million04/16/2024$0.71$0.73+2.59%$0.74$0.7017,735 shs$26.51 million04/15/2024$0.72$0.71-1.84%$0.74$0.716,329 shs$25.84 million04/12/2024$0.72$0.70-2.17%$0.72$0.7022,108 shs$25.48 million04/11/2024$0.73$0.72-1.97%$0.73$0.717,697 shs$26.05 million04/10/2024$0.72$0.73+1.18%$0.76$0.7114,082 shs$26.57 million04/09/2024$0.70$0.72+2.92%$0.77$0.7264,927 shs$26.26 million04/08/2024$0.70$0.70+0.30%$0.76$0.6276,219 shs$25.52 million04/05/2024$0.73$0.70-4.11%$0.73$0.6732,076 shs$25.48 million04/04/2024$0.74$0.73-1.22%$0.75$0.6922,611 shs$26.57 million04/03/2024$0.72$0.74+2.98%$0.75$0.6938,755 shs$26.90 million04/02/2024$0.71$0.72+1.43%$0.73$0.676,951 shs$26.12 million04/01/2024$0.70$0.71+1.62%$0.72$0.686,344 shs$25.75 million03/29/2024$0.70$0.70$0.74$0.6752,714 shs$25.34 million03/28/2024$0.69$0.70+0.19%$0.74$0.6752,347 shs$25.34 million03/27/2024$0.69$0.69+0.56%$0.72$0.6915,019 shs$25.29 million03/26/2024$0.71$0.69-2.68%$0.74$0.6923,113 shs$25.15 million03/25/2024$0.70$0.71+1.37%$0.71$0.705,102 shs$25.84 million03/22/2024$0.69$0.70+1.51%$0.72$0.686,430 shs$25.50 million03/21/2024$0.70$0.69-1.34%$0.72$0.6915,971 shs$25.12 million03/20/2024$0.66$0.70+5.97%$0.71$0.6524,056 shs$25.41 million03/19/2024$0.64$0.66+2.61%$0.68$0.6516,463 shs$23.98 million03/18/2024$0.62$0.64+3.74%$0.67$0.6114,950 shs$23.37 million03/15/2024$0.65$0.62-4.47%$0.67$0.6130,444 shs$22.53 million“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.03/14/2024$0.65$0.65+0.15%$0.67$0.6313,624 shs$23.58 million03/13/2024$0.67$0.65-3.57%$0.72$0.6538,265 shs$23.55 million03/12/2024$0.71$0.67-5.22%$0.71$0.6719,167 shs$24.41 million03/11/2024$0.76$0.71-6.35%$0.77$0.7038,034 shs$25.76 million03/08/2024$0.76$0.76+0.26%$0.77$0.7314,032 shs$27.68 million03/07/2024$0.74$0.76+2.70%$0.78$0.7540,622 shs$27.61 million03/06/2024$0.71$0.74+3.79%$0.75$0.7035,644 shs$26.88 million03/05/2024$0.69$0.71+3.30%$0.71$0.6711,458 shs$25.90 million03/04/2024$0.72$0.69-4.62%$0.72$0.6627,679 shs$25.08 million03/01/2024$0.68$0.72+5.98%$0.73$0.69136,802 shs$26.29 million02/29/2024$0.72$0.68-4.58%$0.72$0.6825,046 shs$24.81 million02/28/2024$0.69$0.72+4.44%$0.73$0.67122,684 shs$26.00 million02/27/2024$0.70$0.69-2.07%$0.70$0.6656,340 shs$24.89 million02/26/2024$0.69$0.70+1.41%$0.70$0.6617,649 shs$25.42 million02/23/2024$0.70$0.69-1.29%$0.70$0.6516,301 shs$25.07 million02/22/2024$0.69$0.70+1.84%$0.70$0.6616,627 shs$25.40 million02/21/2024$0.68$0.69+0.35%$0.70$0.6634,622 shs$24.94 million02/20/2024$0.69$0.68-0.94%$0.70$0.6572,647 shs$24.85 million02/19/2024$0.69$0.69$0.70$0.6626,200 shs$25.09 million02/16/2024$0.70$0.69-0.70%$0.70$0.6626,211 shs$25.09 million02/15/2024$0.69$0.70+0.78%$0.70$0.6766,211 shs$25.27 million02/14/2024$0.66$0.69+4.46%$0.69$0.6413,063 shs$25.07 million02/13/2024$0.68$0.66-3.43%$0.70$0.6528,976 shs$24.00 million02/12/2024$0.63$0.68+8.57%$0.72$0.6052,188 shs$24.85 million02/09/2024$0.63$0.63+0.78%$0.63$0.6017,542 shs$22.89 million Related Companies: ACST Stock Chart UBX Stock Chart APRE Stock Chart NRXP Stock Chart SNSE Stock Chart ITRM Stock Chart LPCN Stock Chart BFRG Stock Chart SPRB Stock Chart BIOR Stock Chart Receive FBRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FBRX) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable ProsperityYou need to know these two things about AI stocks ASAP…InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.